Equities research analysts forecast that OrthoPediatrics Corp. (NASDAQ:KIDS) will report ($0.23) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for OrthoPediatrics’ earnings, with the lowest EPS estimate coming in at ($0.34) and the highest estimate coming in at ($0.12). OrthoPediatrics reported earnings per share of ($0.30) in the same quarter last year, which suggests a positive year over year growth rate of 23.3%. The company is scheduled to report its next quarterly earnings report on Tuesday, May 4th.
According to Zacks, analysts expect that OrthoPediatrics will report full year earnings of ($0.73) per share for the current year, with EPS estimates ranging from ($1.02) to ($0.37). For the next year, analysts anticipate that the business will post earnings of ($0.47) per share, with EPS estimates ranging from ($0.69) to ($0.18). Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that that provide coverage for OrthoPediatrics.
OrthoPediatrics (NASDAQ:KIDS) last released its earnings results on Thursday, March 11th. The company reported ($0.73) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.46). OrthoPediatrics had a negative net margin of 34.26% and a negative return on equity of 11.57%.
KIDS has been the subject of several recent research reports. Piper Sandler boosted their target price on shares of OrthoPediatrics from $55.00 to $62.00 in a research note on Tuesday, April 6th. Zacks Investment Research lowered shares of OrthoPediatrics from a “hold” rating to a “sell” rating in a research report on Friday, March 12th. One research analyst has rated the stock with a sell rating and three have given a buy rating to the company. OrthoPediatrics has a consensus rating of “Buy” and an average target price of $54.50.
In related news, Director David R. Pelizzon bought 3,700 shares of the firm’s stock in a transaction that occurred on Monday, March 15th. The stock was purchased at an average price of $46.50 per share, for a total transaction of $172,050.00. Following the transaction, the director now directly owns 20,900 shares of the company’s stock, valued at approximately $971,850. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gregory A. Odle sold 3,750 shares of the stock in a transaction dated Wednesday, January 27th. The shares were sold at an average price of $51.63, for a total transaction of $193,612.50. Following the completion of the transaction, the executive vice president now owns 76,231 shares of the company’s stock, valued at approximately $3,935,806.53. The disclosure for this sale can be found here. Insiders have sold 47,686 shares of company stock valued at $2,589,408 in the last 90 days. Insiders own 33.60% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in KIDS. California Public Employees Retirement System grew its position in OrthoPediatrics by 2.8% in the 3rd quarter. California Public Employees Retirement System now owns 27,200 shares of the company’s stock valued at $1,249,000 after buying an additional 742 shares in the last quarter. BlackRock Inc. grew its position in OrthoPediatrics by 4.7% in the 3rd quarter. BlackRock Inc. now owns 889,358 shares of the company’s stock valued at $40,840,000 after buying an additional 40,156 shares in the last quarter. State Street Corp lifted its holdings in OrthoPediatrics by 17.7% in the 3rd quarter. State Street Corp now owns 364,061 shares of the company’s stock valued at $16,718,000 after acquiring an additional 54,617 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in OrthoPediatrics by 21.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,942 shares of the company’s stock valued at $230,000 after acquiring an additional 866 shares during the last quarter. Finally, Great West Life Assurance Co. Can lifted its holdings in OrthoPediatrics by 473.2% in the 3rd quarter. Great West Life Assurance Co. Can now owns 6,179 shares of the company’s stock valued at $685,000 after acquiring an additional 5,101 shares during the last quarter. Hedge funds and other institutional investors own 71.74% of the company’s stock.
KIDS stock traded down $0.03 during trading on Wednesday, hitting $49.52. 1,617 shares of the company’s stock traded hands, compared to its average volume of 207,530. OrthoPediatrics has a 52 week low of $38.01 and a 52 week high of $57.42. The stock has a fifty day moving average price of $50.09 and a two-hundred day moving average price of $46.76. The stock has a market capitalization of $973.46 million, a price-to-earnings ratio of -34.37 and a beta of 0.67.
OrthoPediatrics Company Profile
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Recommended Story: Why Invest in Dividend Kings
For more information about research offerings from Zacks Investment Research, visit Zacks.com